Mechanisms of adenosine-induced cytotoxicity and their clinical and physiological implications

Sharmila P Seetulsingh-Goorah1

  • 1Department of Health Sciences, Faculty of Science, University of Mauritius, Redúit, Mauritius. seetulg@uom.ac.mu

Insights

Extracellular ATP (ATPo) and adenosine show potential as anticancer therapies by inducing cancer cell death. Understanding adenosine

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Extracellular ATP (ATPo) and adenosine exhibit cytotoxic effects on various cancer cell lines, indicating therapeutic potential.
  • Adenosine-induced cytotoxicity can occur through exogenous administration or ATPo hydrolysis, involving adenosine receptor activation, pyrimidine starvation, and altered S-adenosylhomocysteine/S-adenosylmethionine ratios.
  • Adenosine may also confer protection against cytotoxicity via antioxidant mechanisms, complicating its role in ATPo-induced cell death.

Purpose of the Study:

  • To elucidate the contribution of adenosine to ATPo-induced cytotoxicity in cancer cells.
  • To address the challenge of distinguishing the independent and combined effects of ATPo and adenosine in cytotoxic mechanisms.
  • To investigate the characteristics of adenosine receptors involved in cytotoxicity.

Main Methods:

  • Utilized a range of ATPo concentrations to assess adenosine's contribution to cytotoxicity.
  • Examined mechanisms including adenosine receptor activation, pyrimidine metabolism, and S-adenosylhomocysteine/S-adenosylmethionine ratios.
  • Considered potential involvement of multiple adenosine receptor subtypes with varying affinities.

Main Results:

  • Adenosine contributes to ATPo-induced cytotoxicity through multiple pathways.
  • Cytotoxic adenosine receptor activation likely requires relatively high adenosine concentrations, suggesting a low-affinity receptor.
  • Lower adenosine concentrations may mediate physiological effects rather than cytotoxicity.

Conclusions:

  • A comprehensive understanding of adenosine's role in ATPo-induced cytotoxicity is critical for developing effective anticancer therapies.
  • Future molecular and pharmacological studies are necessary to identify the specific cytotoxic adenosine receptor(s).
  • The identified cytotoxic adenosine receptor(s) may exhibit low affinity, mediating cell death only at elevated adenosine levels.

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...